COSCIENS Biopharma Selling General Administrative Over Time

CSCI Stock   2.85  0.19  7.14%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out COSCIENS Biopharma Performance and COSCIENS Biopharma Correlation.
For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.
  
The current Selling General Administrative is estimated to decrease to about 3.7 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of COSCIENS Biopharma. If investors know COSCIENS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.69)
Revenue Per Share
3.759
Quarterly Revenue Growth
0.041
Return On Assets
(0.23)
Return On Equity
(0.66)
The market value of COSCIENS Biopharma is measured differently than its book value, which is the value of COSCIENS that is recorded on the company's balance sheet. Investors also form their own opinion of COSCIENS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is COSCIENS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because COSCIENS Biopharma's market value can be influenced by many factors that don't directly affect COSCIENS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between COSCIENS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if COSCIENS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, COSCIENS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Selling General Administrative Analysis

Compare COSCIENS Biopharma and related stocks such as Equillium, DiaMedica Therapeutics, and Valneva SE ADR Selling General Administrative Over Time
201020112012201320142015201620172018201920202021202220232024
EQ378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K3.7 M9.1 M10.2 M11.4 M17.2 M13.6 M10.3 M
DMAC618.5 K2.1 M2.5 M2.5 M1.1 M423.4 K718 K1.3 M2.7 M3.7 M4.4 M4.9 M6.2 M8.2 M8.6 M
VALN3.7 M262 K4.2 M14.7 M14.1 M14.4 M14.4 M15.5 M36.3 M27.5 M38 M47.6 M34.1 M47.8 M24.6 M
VANIMMM4.2 M6.6 M8.2 M10.1 M10.9 M10.7 M9.2 M2.4 M2.3 M7.1 M10 M7.9 M
DNLI5.1 M5.1 M5.1 M5.1 M5.1 M5.1 M11.7 M15.7 M32.3 M46.5 M60.3 M79.1 M90.5 M103.4 M54.3 M
DNTH3.5 M3.5 M3.5 M3.5 M3.5 M3.5 M3.5 M7.8 M18.6 M23.8 M28.1 MM6.7 M18.2 M14.9 M
DOMH15.1 M15.1 M15.1 M15.1 M20.8 M5.1 M4.6 M3.7 M3.1 M3.2 M4.1 M7.7 M11.7 M23.8 M25 M
VCELM7.7 M7.8 M5.9 M13.8 M22.5 M27.4 M35.6 M49 M61.1 M68.8 M97.6 M106.9 M117 M122.9 M
VCNX4.4 M4.4 M4.4 M4.4 M4.4 M4.4 M4.4 M4.5 M4.6 M6.7 M7.4 M6.2 M6.2 M6.9 M6.5 M
VCYT5.4 M5.4 M7.9 M12.1 M18.9 M22.6 M23.8 M23.1 M24 M29 M36.7 M101.4 M76.5 M157.6 M165.5 M

COSCIENS Biopharma and related stocks such as Equillium, DiaMedica Therapeutics, and Valneva SE ADR Selling General Administrative description

My Equities

My Current Equities and Potential Positions

COSCIENS Biopharma
CSCI
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationQuebec; Canada
ExchangeNASDAQ Exchange
null 2.85
When determining whether COSCIENS Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of COSCIENS Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cosciens Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cosciens Biopharma Stock:
Check out COSCIENS Biopharma Performance and COSCIENS Biopharma Correlation.
For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of COSCIENS Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of COSCIENS Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...